☰

Tyisha Hathorn, Ph.D. - Publications

Affiliations: 
2010 Albany Medical College of Union University 
Area:
Neurobiology Biology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Khare S, Nick JA, Zhang Y, Galeano K, Butler B, Khoshbouei H, Rayaprolu S, Hathorn T, Ranum LPW, Smithson L, Golde TE, Paucar M, Morse R, Raff M, Simon J, et al. A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking. Plos One. 12: e0173565. PMID 28467418 DOI: 10.1371/Journal.Pone.0173565  0.339
2014 Armbrust KR, Wang X, Hathorn TJ, Cramer SW, Chen G, Zu T, Kangas T, Zink AN, Öz G, Ebner TJ, Ranum LP. Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9891-904. PMID 25057192 DOI: 10.1523/Jneurosci.0876-14.2014  0.327
2011 Hathorn T, Snyder-Keller A, Messer A. Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease. Neurobiology of Disease. 41: 43-50. PMID 20736066 DOI: 10.1016/J.Nbd.2010.08.017  0.374
2010 Snyder-Keller A, McLear JA, Hathorn T, Messer A. Early or late-stage anti-N-terminal Huntingtin intrabody gene therapy reduces pathological features in B6.HDR6/1 mice. Journal of Neuropathology and Experimental Neurology. 69: 1078-85. PMID 20838238 DOI: 10.1097/Nen.0B013E3181F530Ec  0.373
Show low-probability matches.